2022
Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles
Goutman S, Boss J, Iyer G, Habra H, Savelieff M, Karnovsky A, Mukherjee B, Feldman E. Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle & Nerve 2022, 67: 208-216. PMID: 36321729, PMCID: PMC9957813, DOI: 10.1002/mus.27744.Peer-Reviewed Original ResearchConceptsBody mass indexBody mass index trajectoriesMetabolomic profilesAmyotrophic lateral sclerosis survivalAmyotrophic lateral sclerosisAmyotrophic lateral sclerosis participantsMass indexBody mass index lossBody mass index trajectory groupsSelf-reported body heightParticipants lost weightShorter survivalProspective cohortSurvival associationsStudy entryMetabolomic networksGeneralized estimating equationsSymptom onsetBMI trendsWeight lossSurvivalBile acidsBody heightTrajectory groupsPotential mechanisms
2020
Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database
Abraham H, Xia Y, Mukherjee B, Merajver S. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database. Breast Cancer Research And Treatment 2020, 185: 229-238. PMID: 33033965, DOI: 10.1007/s10549-020-05938-2.Peer-Reviewed Original ResearchConceptsSurvival timeBlack patientsBreast cancerWhite patientsSurvival rateIncidence rateIncidence of IBCInflammatory breast cancerPurposeInflammatory breast cancerResultsThe overall incidenceAge-adjusted incidence ratesMean survival timeRelative survival ratesIBC patientsT stageAggressive variantSkin progressionNo significant differenceDisease criteriaSurvival disparitiesPatientsSignificant differenceSurvivalConfidence intervalsMonths